Smiths Medical and bioAffinity Technologies Partner to Advance Non-Invasive Testing for Early Lung Cancer

PUBLISHED ON October 15, 2020

OCTOBER 15, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, and Smiths Medical, a leading global medical device manufacturer, today announced a partnership to improve patient care with at-home collection of sputum to be analyzed by CyPath® Lung, a non-invasive flow cytometry diagnostic test for lung cancer that is being developed as a Laboratory Developed Test (LDT) by Precision Pathology Services.

read more

Inspirational Women Leaders of Tech: Maria Zannes of bioAffinity Technologies On The Five Things You Need To Know In Order To Create A Very Successful Tech Company

PUBLISHED ON September 26, 2020

Authority Magazine (September 26, 2020) Follow the science. Businesspeople rightfully seek to control a situation, but that does not bode well in the science field. Mother nature has a way of surprising you. Innovation is essential to a biotech company, but it does not reveal itself if you have a limited view of a successful result.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.